REOPRO Trademark

Trademark Overview

On Thursday, April 7, 1994, a trademark application was filed for REOPRO with the United States Patent and Trademark Office. The USPTO has given the REOPRO trademark a serial number of 74512074. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, December 29, 2016. This trademark is owned by Eli Lilly and Company. The REOPRO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of diseases of the circulatory system
reopro

General Information

Serial Number74512074
Word MarkREOPRO
Filing DateThursday, April 7, 1994
Status800 - REGISTERED AND RENEWED
Status DateThursday, December 29, 2016
Registration Number2022377
Registration DateTuesday, December 10, 1996
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 15, 1995

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention and treatment of diseases of the circulatory system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 27, 1994
Primary Code005
First Use Anywhere DateMonday, February 13, 1995
First Use In Commerce DateMonday, February 13, 1995

Trademark Owner History

Party NameJANSSEN BIOTECH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressHORSHAM, PA 19044
Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Wednesday, August 31, 1994ASSIGNED TO EXAMINER
Tuesday, September 13, 1994NON-FINAL ACTION MAILED
Thursday, March 9, 1995EXAMINER'S AMENDMENT MAILED
Saturday, March 11, 1995APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 14, 1995NOTICE OF PUBLICATION
Tuesday, August 15, 1995PUBLISHED FOR OPPOSITION
Friday, September 15, 1995EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 12, 1996NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 14, 1996USE AMENDMENT FILED
Monday, September 16, 1996STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 19, 1996ASSIGNED TO EXAMINER
Wednesday, September 25, 1996ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 10, 1996REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2002PAPER RECEIVED
Tuesday, December 10, 2002REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Saturday, February 22, 2003REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 11, 2006CASE FILE IN TICRS
Monday, December 4, 2006TEAS SECTION 8 & 9 RECEIVED
Monday, December 4, 2006REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, February 9, 2007ASSIGNED TO PARALEGAL
Friday, February 9, 2007REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, February 9, 2007REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, October 18, 2016TEAS SECTION 8 & 9 RECEIVED
Thursday, December 29, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 29, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, December 29, 2016REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, December 29, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, June 7, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 10, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

reopro circulatory system diseases treatment preparations prevention pharmaceutical